Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Cervical Cancer (Oncology) - Drugs in Development, 2021
US$ 2,500.00
Cervical Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cervical Cancer - Drugs In Development, 2021, provid...
October 2021
2171 pages
Chondrosarcoma (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Chondrosarcoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chondrosarcoma - Drugs In Development, 2021, provides...
October 2021
727 pages
Endometrial Cancer (Oncology) - Drugs in Development, 2021
US$ 2,500.00
Endometrial Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Endometrial Cancer - Drugs In Development, 2021,...
October 2021
2259 pages
Ewing Sarcoma (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Ewing Sarcoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ewing Sarcoma - Drugs In Development, 2021, provides a...
October 2021
938 pages
Gallbladder Cancer (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Gallbladder Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gallbladder Cancer - Drugs In Development, 2021,...
October 2021
1118 pages
Gliosarcoma (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Gliosarcoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gliosarcoma - Drugs In Development, 2021, provides an ov...
October 2021
575 pages
Neuroblastoma (Oncology) - Drugs in Development, 2021
US$ 2,500.00
Neuroblastoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuroblastoma - Drugs In Development, 2021, provides a...
October 2021
1265 pages
Non-Hodgkin Lymphoma (Oncology) - Drugs in Development, 2021
US$ 2,500.00
Non-Hodgkin Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Hodgkin Lymphoma - Drugs In Development, 20...
October 2021
4641 pages
Obesity (Metabolic Disorder) - Drugs in Development, 2021
US$ 2,500.00
Obesity (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Obesity - Drugs In Development, 2021, provides an...
October 2021
763 pages
Pontine Glioma (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Pontine Glioma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pontine Glioma - Drugs In Development, 2021, provides...
October 2021
649 pages
Vaginal Cancer (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Vaginal Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vaginal Cancer - Drugs In Development, 2021, provides...
October 2021
579 pages
20s Proteasome - Drugs in Development, 2021
US$ 3,500.00
20s Proteasome - Drugs in Development, 2021 SUMMARY 20s Proteasome pipeline Target constitutes close to 9 molecules. Out of which approximately 6 molecules are developed by companies and remaining by...
September 2021
76 pages
Anaphylaxis (Immunology) - Drugs in Development, 2021
US$ 2,000.00
Anaphylaxis (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anaphylaxis - Drugs In Development, 2021, provides an...
September 2021
67 pages
Aplastic Anemia (Hematology) - Drugs in Development, 2021
US$ 2,000.00
Aplastic Anemia (Hematology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Aplastic Anemia - Drugs In Development, 2021, prov...
September 2021
138 pages
